Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1996
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035778A1 Human uridine diphosphate galactose-4-epimerase
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035719A1 Transeptithelial transport of molecular species
11/14/1996WO1996035718A1 Process for producing erythropoietin containing no animal proteins
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035715A2 Pcna binding substance
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035706A1 Pyrimidine targeting hairpin triplex-forming oligonucleotides
11/14/1996WO1996035705A1 Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion
11/14/1996WO1996035704A1 Method for detection of neoplastic cells
11/14/1996WO1996035703A1 Human inhibitor of apoptosis gene 1
11/14/1996WO1996035453A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy
11/14/1996WO1996035449A1 Monoclonal antibodies for the treatment of ulcerative colitis
11/14/1996WO1996035448A1 Preventive for postoperative astigmatism
11/14/1996WO1996035447A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
11/14/1996WO1996035446A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035444A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
11/14/1996WO1996035443A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996WO1996035439A1 Low molecular yeast active substance extract and process for preparing the same
11/14/1996WO1996035433A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
11/14/1996WO1996035430A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-λB
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/14/1996WO1996035415A2 Use of sesquiterpenes for inhibiting oxidative enzymes
11/14/1996WO1996035408A1 Cosmetic deodorant compositions containing encapsulated bicarbonate
11/14/1996WO1996032087A3 Transgenic fish in the treatment of diabetes
11/14/1996WO1996028470A3 Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
11/14/1996WO1996027008A3 Agent for treating tumours and other hyperplasia
11/14/1996WO1996025501A3 Method and composition for regulating apoptosis
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19517430A1 Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode The pharmaceutical dosage form of parathyroid hormone with a two- to six-hour drug release period
11/14/1996DE19516776A1 Chromatin-Regulatorgene Chromatin regulator genes
11/14/1996CA2221035A1 Tripeptidylpeptidase inhibitors
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220897A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220677A1 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
11/14/1996CA2220670A1 Human inhibitor of apoptosis gene 1
11/14/1996CA2220497A1 Kunitz type protease inhibitors
11/14/1996CA2220106A1 Inhibition of amylin release
11/14/1996CA2219877A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996CA2219770A1 Human uridine diphosphate galactose-4-epimerase
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/14/1996CA2218327A1 Pcna binding substance
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742228A1 IGF-1 superagonists
11/13/1996EP0742013A1 Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
11/13/1996EP0742012A2 Pharmaceutical composition containing substance inhibiting HSP47 production
11/13/1996EP0741793A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/13/1996EP0741788A1 Inducing tolerance with tolerogenic fusion proteins
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741747A1 Inhibitors of serine proteases, bearing a chelating group
11/13/1996EP0741746A1 Analogs of thymosin alpha 1
11/13/1996EP0741743A1 Cyclic neurokinin a antagonists
11/13/1996EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
11/13/1996EP0741696A1 Malarial aspartic protease inhibitors
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741579A1 Aqueous prolonged release formulation
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741577A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
11/13/1996EP0741576A1 Co-administration of interleukin-3 mutants with colony stimulating factors
11/13/1996EP0741575A1 Human therapeutic uses of bpi protein products
11/13/1996EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
11/13/1996EP0607156B1 Process for producing preserved medicaments containing human proteins for the purposes of infusion or injection
11/13/1996EP0474691B1 Monoclonal antibodies for inducing tolerance
11/13/1996EP0434744B1 Serum immunoregulatory polypeptide and uses therefor
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/13/1996CN1135760A Anti-thrombus active piptide and preparation method thereof
11/13/1996CN1135720A Biodegradable medicinal polymer assembly with supermolecular structure
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
11/13/1996CN1135717A Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
11/13/1996CN1135358A Medicine for treatment of restenosis and arteriosclerosis
11/13/1996CN1135357A Medicinal composition for treatment of unmatured catarct
11/13/1996CN1135295A Feed for crustacean and feed additive
11/12/1996US5574656 System and method of automatically generating chemical compounds with desired properties
11/12/1996US5574206 Transgenic mouse carrying a non-infectious HIV genome
11/12/1996US5574205 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/12/1996US5574143 Ribozymes
11/12/1996US5574138 Epithelium-derived T-cell factor
11/12/1996US5574137 Recombinant gamma interferons having enhanced stability and methods therefor
11/12/1996US5574133 Anti-obesity proteins
11/12/1996US5574068 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
11/12/1996US5574024 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
11/12/1996US5574022 Method of attenuating physical damage to the spinal cord
11/12/1996US5574017 Inhibit bacterial cell wall biosynthesis
11/12/1996US5574016 Anticoagulants and cardiovascular disorders
11/12/1996US5574015 Isosteric antiherpes peptide derivatives
11/12/1996US5574014 Inhibitors of trypsin-like enzymes
1 ... 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 ... 3163